DK2310043T3 - Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere - Google Patents

Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere

Info

Publication number
DK2310043T3
DK2310043T3 DK09777111.7T DK09777111T DK2310043T3 DK 2310043 T3 DK2310043 T3 DK 2310043T3 DK 09777111 T DK09777111 T DK 09777111T DK 2310043 T3 DK2310043 T3 DK 2310043T3
Authority
DK
Denmark
Prior art keywords
von willebrand
factor
willebrand factor
treatment
platelet inhibitors
Prior art date
Application number
DK09777111.7T
Other languages
English (en)
Other versions
DK2310043T4 (da
Inventor
Henrique Lessa
Thorsten Haas
Stefan Zeitler
Gerhard Dickneite
Ingo Pragst
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41171229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2310043(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Application granted granted Critical
Publication of DK2310043T3 publication Critical patent/DK2310043T3/da
Publication of DK2310043T4 publication Critical patent/DK2310043T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09777111.7T 2008-07-10 2009-07-10 Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere DK2310043T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008032361A DE102008032361A1 (de) 2008-07-10 2008-07-10 Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
PCT/EP2009/005027 WO2010003687A1 (en) 2008-07-10 2009-07-10 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes

Publications (2)

Publication Number Publication Date
DK2310043T3 true DK2310043T3 (da) 2013-01-07
DK2310043T4 DK2310043T4 (da) 2022-06-20

Family

ID=41171229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09777111.7T DK2310043T4 (da) 2008-07-10 2009-07-10 Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere

Country Status (13)

Country Link
US (2) US8603979B2 (da)
EP (1) EP2310043B2 (da)
JP (1) JP5653916B2 (da)
KR (1) KR20110043654A (da)
CN (1) CN102088999A (da)
AU (1) AU2009268289B2 (da)
CA (1) CA2730290C (da)
DE (1) DE102008032361A1 (da)
DK (1) DK2310043T4 (da)
ES (1) ES2395855T5 (da)
PL (1) PL2310043T5 (da)
RU (1) RU2563236C2 (da)
WO (1) WO2010003687A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2244814B1 (en) * 2007-12-28 2021-06-02 Takeda Pharmaceutical Company Limited Recombinant vwf formulations
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2391613T3 (es) * 2008-06-24 2012-11-28 Octapharma Ag Un procedimiento para purificar el factor de coagulación VIII
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
NZ592704A (en) 2008-10-21 2013-02-22 Baxter Int Lyophilized recombinant von willebrand factor (rVWF) formulation comprising buffering agents, amino acids, stabilising agents and surfactants
LT2804623T (lt) 2012-01-12 2019-12-10 Bioverativ Therapeutics Inc Chimeriniai viii faktoriaus polipeptidai ir jų panaudojimas
WO2013083858A1 (en) 2012-04-24 2013-06-13 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
EP2662083A1 (en) 2012-05-08 2013-11-13 CSL Behring GmbH Sugar compositions for treating hemophilia a and/or von willebrand disease
CN102776260B (zh) * 2012-07-26 2015-04-29 上海泰龙生物医药科技有限公司 一种高效表达重组人凝血八因子的方法
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
CN103263663B (zh) * 2013-06-08 2016-05-04 兆科药业（合肥）有限公司 一种抗血小板溶栓素在制备治疗vwf缺陷型血管栓塞性疾病的药物中的应用
US10231993B2 (en) 2013-06-27 2019-03-19 University Of Washington Through Its Center For Commercialization Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430205A1 (de) 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
US6518482B2 (en) 1994-09-13 2003-02-11 American National Red Cross Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor
DE4437544A1 (de) * 1994-10-20 1996-04-25 Behringwerke Ag Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika
FR2744918B1 (fr) 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
CN1208088C (zh) † 1999-12-24 2005-06-29 财团法人化学及血清疗法研究所 预防和治疗与血小板紊乱有关的出血性疾病的药用组合物
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie

Also Published As

Publication number Publication date
AU2009268289A1 (en) 2010-01-14
RU2563236C2 (ru) 2015-09-20
WO2010003687A1 (en) 2010-01-14
US20110112023A1 (en) 2011-05-12
JP2011527301A (ja) 2011-10-27
AU2009268289B2 (en) 2014-11-06
US20140128325A1 (en) 2014-05-08
EP2310043B2 (en) 2022-05-18
RU2011104705A (ru) 2012-08-20
PL2310043T5 (pl) 2024-02-05
ES2395855T3 (es) 2013-02-15
CA2730290A1 (en) 2010-01-14
DK2310043T4 (da) 2022-06-20
JP5653916B2 (ja) 2015-01-14
US9095564B2 (en) 2015-08-04
EP2310043B1 (en) 2012-09-19
CA2730290C (en) 2017-02-07
US8603979B2 (en) 2013-12-10
KR20110043654A (ko) 2011-04-27
ES2395855T5 (es) 2022-09-06
PL2310043T3 (pl) 2013-02-28
EP2310043A1 (en) 2011-04-20
DE102008032361A1 (de) 2010-01-21
CN102088999A (zh) 2011-06-08

Similar Documents

Publication Publication Date Title
DK2310043T3 (da) Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere
DE602007006451D1 (de) Verfahren zur behandlung von bohrlöchern mit wiederverwertbaren flüssigkeiten
DE602008000298D1 (de) Verfahren zur Herstellung von Polyesternanokompositen
AT10541U2 (de) Vorrichtung zur bestimmung der konzentration von feststoffpartikeln
DE112011100117A5 (de) Verfahren zur automatischen prävention von aquaplaning
AT504436B8 (de) Verfahren und vorrichtung zur bestimmung des alkoholgehaltes von flüssigkeiten
BRPI0911060A2 (pt) polipeptídeos de fator vii que são modificados e usos dos mesmos
DE502007003872D1 (de) Verfahren und vorrichtung zur vermeidung und/oder minderung der folgen von kollisionen
DE602006008931D1 (de) Verfahren zur Oligomerisierung von Ethylen und/oder alpha-Olefinen
AT505105A3 (de) Verfahren zur beurteilung der fahrbarkeit von fahrzeugen
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
DE602007005747D1 (de) System zur Entfernung von Kalkablagerungen
DK2006367T3 (da) Filtrerings- og/eller flokkuleringsmidler til oprensning af flydende fødevarer
DE602009000585D1 (de) Vorrichtung zur Detektion der Position von flüssigen Oberflächen und Bestimmung des Flüssigkeitsvolumens
DE602008002968D1 (de) Gerät zur Herstellung von RFID-Etiketten
FI20085969A0 (fi) Hapan vesi ja sen käyttö vedenpoistoon tai kiintoaineiden erottamiseen
AT508863A3 (de) Fördereinrichtung und verfahren zur ermittlung der reihenfolge von antrieben
DE502004005365D1 (de) Verfahren zur quantitativen Messung von Ablagerung auf festen Oberflächen
ATE543383T1 (de) Verfahren zur verzögerung der reife von erntegut
ATE516805T1 (de) Medikament zur behandlung von endometriose
DE602009000789D1 (de) Perfektionierte Vorrichtung zur Auswahl von Postartikeln
DE602009000441D1 (de) Vorrichtung zur optimierten Auswahl von Postartikeln
DE102011106859A8 (de) Verfahren und Vorrichtung zur kontinuierlichen Beschichtung von Substraten
DE502006005974D1 (de) Nutzung von Variablen in mehreren Automatisierungssystemen
DE602006020620D1 (de) Verwendung von tiotropium-salzen bei der behandlung von mässigem persistierendem asthma